医学化学项目如何改变前列腺癌的诊断和治疗方式
Alan P Kozikowski1, Joseph Neale2
1Prostate Theranostics Inc., 1 Research Court, Suite 450, Rockville, Maryland 20850, United States.
Journal of medicinal chemistry
|October 6, 2025
概括
研究人员开发了针对PSMA的尿素基联体,彻底改变了前列腺癌的诊断和治疗,使用Pylarify和Pluvicto等放射性药物. 这一突破使得先进的癌症成像和治疗策略成为可能.
科学领域:
- 在瘤学瘤学.
- 放射性药物化学 放射性药物化学
- 药物开发 药物开发
背景情况:
- 前列腺特异性膜抗原 (PSMA),也称为GCPII,是前列腺癌的关键标.
- 早期的研究重点是神经递质类似物和酸衍生物用于PSMA抑制.
研究的目的:
- 为了突出开发PSMA向的尿素基联结体.
- 展示针对PSMA的放射性药物的临床成功.
- 探索正在进行的PSMA准天文学的创新.
主要方法:
- 从NAAG和酸衍生物开始合理的药物设计.
- 进化到具有高抑制活性的简化Glu-urea支架.
- 诊断和治疗的放射性连接体和小分子药物联合体 (SMDCs) 的开发.
主要成果:
- 放射性药物Pylarify和Pluvicto在前列腺癌的成功临床应用.
- 创建有效的诊断和治疗PSMA向剂.
- 新型SMDC和双功能准策略的出现.
结论:
- 针对PSMA的尿素基联体已经改变了前列腺癌的成像和治疗.
- 合作的化学和生物学努力重新定义了癌症治疗学.
- 未来的方向包括替代的结合动机和脑透抑制剂.
更多相关视频
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
17.1K
08:05Detection and Isolation of Cancer in Prostate Biopsies Using Stimulated Raman Histology and Artificial Intelligence
Published on: June 10, 2025
1.1K
相关概念视频
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
